Molecular Imaging For Whole Body Visualisation Of Diseases

Active Fellowship

  • Dr Maria Rosa Gigliobianco

    With a background in Pharmaceutical Chemistry (2011-2018), Dr Maria Rosa Gigliobianco was mainly focused on the development of biopolymers synthesis as innovative DDs. Her professional interest involves the advancement of biopolymer applications to improve therapeutic intervention for the treatment of cancer. During her PhD at the University of Camerino (Italy), she has been successful in the development, optimisation, and preclinical evaluation of smart biodegradable nano-systems for different biomedical applications. She then had a postdoctoral experience with a fellowship at the University of Camerino focusing on the investigation of new natural bioactive compounds and the development of new technology systems based on the natural substrate for the release of active molecules that will be applied for a patent. Since her PhD, she has been able to keep publishing regularly in indexed peer-reviewed journals in the field of pharmaceutical technologies, drug delivery design systems, nanotechnology, completed the supervision of 3 doctoral students and 20 master students as principal advisor. Based on these achievements, GELNANODEP is fully aligned with Dr Gigliobianco’s expertise and will contribute to her goal of becoming a leader in the field of advance release drug systems in therapeutic medicine.

  • Dr. Alessandra Affinito


    Dr. Affinito studied Pharmacy at Federico II University of Naples, Italy. She obtained her PhD, from the same university, in Molecular Medicine and Medical Biotechnology in 2018. Dr. Affinito has worked in Prof Condorelli's laboratories where she held her two postdoctoral positions. Dr. Affinito’s attitude in different approaches encouraged her to participate in the Erasmus Plus Program and won a 3-month fellowship of Prof Patrick Arbuthnot's lab - Antiviral Gene Therapy Research Unit - at the University of the Witwatersrand in Johannesburg (South Africa). Dr. Affinito’s main research interest is in the development of RNA aptamers as an innovative therapeutic and diagnostic tool in several types of cancers. Indeed, she has recently won a Marie Skłodowska-Curie Individual Fellowships 2020, which is focused on an innovative tool to detect Glioblastoma exosomes on liquid biopsy-based on synthetic aptamer.

  • Dr. Giuseppina Roscigno


    Dr. Giuseppina Roscigno graduaded in Biology at Federico II University of Naples. She finished her PhD in Oncology and Molecular Endocrinology in 2014. During her Phd program, Dr. Roscigno focus on the role of microRNAs in breast cancer cells stem regulation. In the meantime, she participated to the Erasmus program and had the possibility to work on cancer epigenetic at the Institut d’Investigacion Biomedica de Bellvige-Programa d’Epigenetica i Biologia del Cancer (Barcelona-ES). In the academic sector, Dr. Roscigno succeeded in several post-Doc fellowships (Fondazione Veronesi grants), and the main topic of her researches were the development of organoids cultures starting from patients’ surgery biopsy and set up of a chemotaxis method to determine migratory capacity of tumor organoids cells. Furthermore, she has recently won a Marie Skłodowska-Curie Individual Fellowships 2020, which is focused on an organoid on chip development as tool for patient unique drug screening profile and for giving pre-clinical information in a personalized form.

  • Dr. Vijay Kumar


    Dr. Vijay Kumar is a pharmacy professional and obtained his PhD in Nanomedicine and Drug Delivery from the University of Delhi, India in 2018. Dr Vijay qualified national levels exams (GPAT, GATE) in India and worked in close collaboration with various national level institutes. After PhD, he joined SFI Research Centre for Medical Devices, NUI Galway, Ireland as a MedTrain Marie-Sklodowska Curie Postdoctoral fellow for 2 years in 2018 and worked to develop functionalized biomaterials for various biomedical applications in an Internationally collaborative environment. His main interest is developing therapeutic biomaterials for cancer and other inflammatory diseases. Recently he was awarded Marie Skłodowska-Curie Individual Fellowship 2020 focusing on engineering exosomes to treat non-small cell lung cancer."